HL7 FHIR® Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment)

This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions

MammaprintRiskScoreInterpretationVS


<ValueSet xmlns="http://hl7.org/fhir">
  <id value="oncology-MammaprintRiskScoreInterpretationVS"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
<p><b>BC MammaprintRiskScoreInterpretationVS ValueSet</b></p>
<p>Intepretation of Mammaprint Recurrence Score</p>
</div>
  </text>
  <url
       value="http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-MammaprintRiskScoreInterpretationVS"/>
  <identifier>
    <system value="http://hl7.org/fhir/us/breastcancer"/>
    <value value="oncology.MammaprintRiskScoreInterpretationVS"/>
  </identifier>
  <version value="0.1.0"/>
  <name value="MammaprintRiskScoreInterpretationVS"/>
  <title value="BC MammaprintRiskScoreInterpretationVS ValueSet"/>
  <status value="draft"/>
  <date value="2018-04-01T00:00:00+11:00"/>
  <publisher
             value="The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://standardhealthrecord.org"/>
    </telecom>
  </contact>
  <description value="Intepretation of Mammaprint Recurrence Score"/>
  <compose>
    <include>
      <system
              value="http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-MammaprintRiskScoreInterpretationCS"/>
      <concept>
        <code value="low_risk"/>
        <display
                 value="Score between 0.0 and +1.0, meaning a patient has on average a 10% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy."/>
      </concept>
      <concept>
        <code value="high_risk"/>
        <display
                 value="Score between -1.0 and 0.0, meaning a patient has a 29% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy."/>
      </concept>
    </include>
  </compose>
</ValueSet>